The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells

Por Salem, Israa, Alsalahi, Manal, Chervoneva, Inna, Aburto, Lucy D., Addya, Sankar, Ott, Gregory R., Ruggeri, Bruce A., Cristofanilli, Massimo, Fernandez, Sandra V.
Publicado no Breast Cancer Res (2016)

Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity

Por Ott, Gregory R., Tripathy, Rabindranath, Cheng, Mangeng, McHugh, Robert, Anzalone, Andrew V., Underiner, Ted L., Curry, Matthew A., Quail, Matthew R., Lu, Lihui, Wan, Weihua, Angeles, Thelma S., Albom, Mark S., Aimone, Lisa D., Ator, Mark A., Ruggeri, Bruce A., Dorsey, Bruce D.
Publicado em 2010

Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment

Por Mirza, Amar N., Fry, Micah A., Urman, Nicole M., Atwood, Scott X., Roffey, Jon, Ott, Gregory R., Chen, Bin, Lee, Alex, Brown, Alexander S., Aasi, Sumaira Z., Hollmig, Tyler, Ator, Mark A., Dorsey, Bruce D., Ruggeri, Bruce R., Zificsak, Craig A., Sirota, Marina, Tang, Jean Y., Butte, Atul, Epstein, Ervin, Sarin, Kavita Y., Oro, Anthony E.
Publicado no JCI Insight (2017)